SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Översikt
- 5–9
- Anställda
- 5–10milj SEK
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+18 fler kontakter i Funnelfeedr
Beskrivning
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559058482601
Beslutsfattare
22 kontakter i FunnelfeedrAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Björn Westberg
Chief Financial Officer
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen, PhD.
Chief Operating Officer
Sten Sørensen
Board Member
Thomas Boesen
Chief Operating Officer
Thomas Jonassen, MD.
Chief Scientific Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Liknande företag
20 liknande företag i FunnelfeedrSynartro AB
1–4 anställdaDeveloping sustained local injection treatments for osteoarthritis pain relief.
Pharmnovo Aktiebolag
1–4 anställdaDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Sangair AB
3 anställdaDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Novakand Pharma AB
5–9 anställdaDeveloping novel small-molecule drugs for inflammation and cancer.
PILA PHARMA AB
1–4 anställdaClinical stage biotech developing an oral obesity and diabetes treatment.
Utforska mer
Frågor om SynAct Pharma AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo